A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis (Q78472012)
Jump to navigation
Jump to search
scientific article published on 01 November 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis |
scientific article published on 01 November 2002 |
Statements
A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis (English)
Leo van de Putte
Rolf Rau
Manfred Schattenkirchner
Piet Van Riel
Christina Binder
Helmut Fenner
Yvonne Bankmann
Raja Velagapudi
Joachim Kempeni
Hartmut Kupper
1 November 2002